| Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling Y Shi, W Zheng, K Yang, KG Harris, K Ni, L Xue, W Lin, EB Chang, ... Journal of Experimental Medicine 217 (5), e20192282, 2020 | 216 | 2020 |
| A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control Z Sun, Z Ren, K Yang, Z Liu, S Cao, S Deng, L Xu, Y Liang, J Guo, Y Bian, ... Nature communications 10 (1), 3874, 2019 | 161 | 2019 |
| Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade W Si, H Liang, J Bugno, Q Xu, X Ding, K Yang, Y Fu, RR Weichselbaum, ... Gut 71 (3), 521-533, 2022 | 125 | 2022 |
| Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse Y Pu, M Xu, Y Liang, K Yang, Y Guo, X Yang, YX Fu Science translational medicine 8 (333), 333ra47-333ra47, 2016 | 108 | 2016 |
| Dual targeting of innate and adaptive checkpoints on tumor cells limits immune evasion X Liu, L Liu, Z Ren, K Yang, H Xu, Y Luan, K Fu, J Guo, H Peng, M Zhu, ... Cell reports 24 (8), 2101-2111, 2018 | 100 | 2018 |
| Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation K Yang, Y Hou, Y Zhang, H Liang, A Sharma, W Zheng, L Wang, R Torres, ... Journal of Experimental Medicine 218 (3), e20201915, 2021 | 58 | 2021 |
| Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration K Yang, W Han, X Jiang, A Piffko, J Bugno, C Han, S Li, H Liang, Z Xu, ... Nature Nanotechnology 17 (12), 1322-1331, 2022 | 53 | 2022 |
| Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework K Ni, Z Xu, A Culbert, T Luo, N Guo, K Yang, E Pearson, B Preusser, T Wu, ... Nature biomedical engineering 6 (2), 144-156, 2022 | 50 | 2022 |
| RIG-I–like receptor LGP2 is required for tumor control by radiotherapy W Zheng, DRE Ranoa, X Huang, Y Hou, K Yang, EC Poli, MA Beckett, ... Cancer research 80 (24), 5633-5641, 2020 | 31 | 2020 |
| All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages E Rao, Y Hou, X Huang, L Wang, J Wang, W Zheng, H Yang, X Yu, ... Science immunology 6 (60), eaba8426, 2021 | 29 | 2021 |
| YTHDF2 inhibition potentiates radiotherapy antitumor efficacy L Wang, X Dou, S Chen, X Yu, X Huang, L Zhang, Y Chen, J Wang, ... Cancer Cell 41 (7), 1294-1308. e8, 2023 | 24 | 2023 |
| Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy X Jiang, W Han, J Liu, J Mao, MJ Lee, M Rodriguez, Y Li, T Luo, Z Xu, ... Advanced Science 9 (24), 2201614, 2022 | 15 | 2022 |
| Converting lymphoma cells into potent antigen-presenting cells for interferon-induced tumor regression J Liao, Y Luan, Z Ren, X Liu, D Xue, H Xu, Z Sun, K Yang, H Peng, YX Fu Cancer immunology research 5 (7), 560-570, 2017 | 12 | 2017 |
| Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication Y Liang, K Yang, J Guo, J Wroblewska, YX Fu, H Peng Scientific reports 5 (1), 10406, 2015 | 10 | 2015 |
| T cell-derived lymphotoxin is essential for the anti-herpes simplex virus 1 humoral immune response K Yang, Y Liang, Z Sun, D Xue, H Xu, M Zhu, YX Fu, H Peng Journal of virology 92 (14), 10.1128/jvi. 00428-18, 2018 | 7 | 2018 |
| T cell-derived lymphotoxin limits Th1 response during HSV-1 infection K Yang, Y Liang, Z Sun, L Liu, J Liao, H Xu, M Zhu, YX Fu, H Peng Scientific reports 8 (1), 17727, 2018 | 6 | 2018 |
| Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control Z Sun, Z Ren, K Yang, Z Liu, S Cao, S Deng, L Xu, Y Liang, J Guo, Y Bian, ... Nature communications 11 (1), 1716, 2020 | 3 | 2020 |
| Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy J Liu, X Jiang, Y Li, K Yang, RR Weichselbaum, W Lin ACS nano, 2024 | 1 | 2024 |
| Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance L Wang, W Si, X Yu, A Piffko, X Dou, X Ding, J Bugno, K Yang, C Wen, ... Journal of Clinical Investigation 133 (24), e172919, 2023 | 1 | 2023 |
| Radiotherapy Enhances Metastasis Through Immune Suppression by inducing PD-L1 and MDSC in distal sites Y Hou, K Yang, L Wang, J Wang, X Huang, A Piffko, SZ Luo, X Yu, E Rao, ... Clinical Cancer Research, 2024 | | 2024 |
